派博傳思國際中心

標(biāo)題: Titlebook: Cancer Chemo- and Immunopharmacology; 1. Chemopharmacology Georges Mathé,Franco M. Muggia Book 1980 Springer-Verlag Berlin Heidelberg 1980 [打印本頁]

作者: Jurisdiction    時(shí)間: 2025-3-21 18:07
書目名稱Cancer Chemo- and Immunopharmacology影響因子(影響力)




書目名稱Cancer Chemo- and Immunopharmacology影響因子(影響力)學(xué)科排名




書目名稱Cancer Chemo- and Immunopharmacology網(wǎng)絡(luò)公開度




書目名稱Cancer Chemo- and Immunopharmacology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Chemo- and Immunopharmacology被引頻次




書目名稱Cancer Chemo- and Immunopharmacology被引頻次學(xué)科排名




書目名稱Cancer Chemo- and Immunopharmacology年度引用




書目名稱Cancer Chemo- and Immunopharmacology年度引用學(xué)科排名




書目名稱Cancer Chemo- and Immunopharmacology讀者反饋




書目名稱Cancer Chemo- and Immunopharmacology讀者反饋學(xué)科排名





作者: 背書    時(shí)間: 2025-3-22 00:16

作者: 郊外    時(shí)間: 2025-3-22 01:53
https://doi.org/10.1007/978-3-642-67931-5 drugs, and interhost immune responses. In contrast, human tumors (e.g., ovarian carcinoma) show much greater variability. It is suggested that greater attention should be given to the study of the variables which distinguish the clinical setting from the animal models.
作者: homocysteine    時(shí)間: 2025-3-22 06:06
Psychosomatische St?rung und Neuroseolid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.
作者: 潛伏期    時(shí)間: 2025-3-22 10:05
https://doi.org/10.1007/978-3-319-47542-4of the testes, but also in ovarian carcinoma, in melanoma, and in epidermoid carcinoma, especially of the head and of the uterus cervix. Its toxicity, manifested mainly in the digestive and renal tracts, confines its administration to hospitalized patients only. This compound is now indicated in combination therapy for the above-mentioned tumors.
作者: CLAY    時(shí)間: 2025-3-22 15:03

作者: CLAY    時(shí)間: 2025-3-22 17:17
N-(Phosphonacetyl)-,-Aspartate (PALA): Current Status,olid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.
作者: 歡騰    時(shí)間: 2025-3-22 23:41

作者: 承認(rèn)    時(shí)間: 2025-3-23 05:06
Bedingungen neurotischer EntwicklungThe inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.
作者: aspect    時(shí)間: 2025-3-23 06:09
Clinical Chemotherapy: Its Correlation with Experimental Models,The inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.
作者: Finasteride    時(shí)間: 2025-3-23 11:06

作者: BATE    時(shí)間: 2025-3-23 15:06
Alessio Plebe,Vivian M. De La Cruz control successfully than grave infectious diseases such as tuberculosis. This will likely be so, even when moderately successful chemotherapy is or will be available. Nevertheless, prospects for improving current results are present through application of chemo- therapy alone or in combination wit
作者: EWER    時(shí)間: 2025-3-23 18:40
Bedingungen neurotischer Entwicklungt randomized clinical trials, either unicentric or policentric, are discussed..As fas as pediatric tumors are concerned post-surgical adjuvant chemotherapy was proved to play a useful role in prolonging the disease-free survival in Wilms tumor, rhabdomyosarcoma, Ewing sarcoma. Results obtained in th
作者: 淡紫色花    時(shí)間: 2025-3-24 00:54
https://doi.org/10.1007/978-3-642-67931-5 drugs, and interhost immune responses. In contrast, human tumors (e.g., ovarian carcinoma) show much greater variability. It is suggested that greater attention should be given to the study of the variables which distinguish the clinical setting from the animal models.
作者: 支柱    時(shí)間: 2025-3-24 03:47
Pers?nlichkeitsst?rung und Neurosemethylpteroic acid, and methotrexate poly-.-glutamates have been established as products of metabolic conversion in man. The significance of the formation of these metabolites has not been firmly established. Certain of these compounds may play a role in the development of the renal failure syndrome
作者: tariff    時(shí)間: 2025-3-24 09:18

作者: 運(yùn)氣    時(shí)間: 2025-3-24 13:20
Pers?nlichkeitsst?rung und Neurosecin, and vincristine in 21 patients with extensive-stage small cell lung cancer. Nine (42%) of 21 had a complete remission. The median duration of remission has been short (5 months), and attempts are now under way to improve consolidation chemotherapy. In general, the degree of myelotoxicity was no
作者: Fallibility    時(shí)間: 2025-3-24 18:35
https://doi.org/10.1007/978-3-642-67931-5advanced malignancies. DCM was tolerated without Leucovorin (calcium folinate) in man, even when the initial immunoassayable DCM level approached 10... Hepatic dysfunction occurred more frequently at high doses. Hematologic toxicity was not dose-limiting. Plasma decay of DCM was comparable to that o
作者: 斜坡    時(shí)間: 2025-3-24 19:44

作者: 小臼    時(shí)間: 2025-3-25 01:07
Psychosomatische St?rung und Neuroseolid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.
作者: Slit-Lamp    時(shí)間: 2025-3-25 05:46
Pers?nlichkeitsst?rung und Neurosef adenine inhibit the growth of some tumor cell lines in vitro and in vivo. 2’-Azidoarabinofuranosyl cytosine also interferes with the replication of herpes simplex virus types I and II. Whereas 2’-azidoara-C is resistant to deamination by a partially purified CdR deaminase from KB cells, the adenin
作者: conscribe    時(shí)間: 2025-3-25 08:40

作者: Volatile-Oils    時(shí)間: 2025-3-25 14:23

作者: archenemy    時(shí)間: 2025-3-25 18:18

作者: SIT    時(shí)間: 2025-3-25 20:26
Die Rehabilitation von Neurosekrankenthis series bind with high affinity to DNA (affinity constant between 10... and 10...) by intercalation between base pairs. The antitumoral properties of these derivatives are thought to be related to their DNA-binding ability. Both 9-hydroxylation of ellipticine and quaternarization of 2-pyridinic
作者: progestogen    時(shí)間: 2025-3-26 03:13

作者: 噴油井    時(shí)間: 2025-3-26 04:40

作者: generic    時(shí)間: 2025-3-26 12:12

作者: Thrombolysis    時(shí)間: 2025-3-26 13:32
https://doi.org/10.1007/978-3-642-81488-4Cancer; Chemotherapeutikum; Immunopharmakologie; Immunotherapie; Krebs; Zytostatikum; surgery
作者: Archipelago    時(shí)間: 2025-3-26 19:18
978-3-642-81490-7Springer-Verlag Berlin Heidelberg 1980
作者: PATRI    時(shí)間: 2025-3-26 21:28
Biochemical Control of High-Dose Methotrexate/Leucovorin Rescue Therapy,/.H-thymidine (dTR) incorporation into the DNA of the cells is a good biochemical parameter for estimating the MTX effect on rapidly proliferating cell systems. Using this indicator, it was shown that the usually administered dose of Leucovorin is not sufficient for an effective rescue of the bone m
作者: Ligneous    時(shí)間: 2025-3-27 04:20
Vindesine: A New Vinca Alkaloid,asthenia, and muscle pains. The results are better if the patients have not been treated previously; continuous infusion could be of interest and there appears to be no cross-resistance with its parent VCR, as documented in ALL.
作者: 豐富    時(shí)間: 2025-3-27 05:38

作者: atopic    時(shí)間: 2025-3-27 13:05

作者: 性行為放縱者    時(shí)間: 2025-3-27 15:51
Comparative Pharmacokinetics of Chlorambucil and Melphalan in Man,
作者: 多山    時(shí)間: 2025-3-27 18:31
Die Rehabilitation von Neurosekranken/.H-thymidine (dTR) incorporation into the DNA of the cells is a good biochemical parameter for estimating the MTX effect on rapidly proliferating cell systems. Using this indicator, it was shown that the usually administered dose of Leucovorin is not sufficient for an effective rescue of the bone m
作者: 勤勞    時(shí)間: 2025-3-27 22:03

作者: 產(chǎn)生    時(shí)間: 2025-3-28 04:30
Die Rehabilitation von Neurosekrankenblood pressure are the most noticeable cardiovascular effects in dogs..This compound administered at 80–100 mg/m./week in 1-h intravenous (IV) infusion induces objective remissions in about 25% of patients suffering from advanced breast cancer refractory to all other treatment. These remissions, whi
作者: glomeruli    時(shí)間: 2025-3-28 08:40
Course, Outcome and its Evaluation,um derivatives seem to fit these criteria. In the experimental animal renal toxicity does not appear to be limiting [10], and in mouse leukemia there is no cross-resistance to DDP [2, 3]. The dichloro, malonato, and carboxyphthalato derivatives of 1,2-diaminocyclohexane platinum experimentally have
作者: 壓艙物    時(shí)間: 2025-3-28 11:25

作者: 寬容    時(shí)間: 2025-3-28 17:37
Adjuvant Therapies of Postsurgical Minimal Residual Disease,t randomized clinical trials, either unicentric or policentric, are discussed..As fas as pediatric tumors are concerned post-surgical adjuvant chemotherapy was proved to play a useful role in prolonging the disease-free survival in Wilms tumor, rhabdomyosarcoma, Ewing sarcoma. Results obtained in th
作者: oracle    時(shí)間: 2025-3-28 19:59
Limits of Animal Models in Cancer Chemotherapy, drugs, and interhost immune responses. In contrast, human tumors (e.g., ovarian carcinoma) show much greater variability. It is suggested that greater attention should be given to the study of the variables which distinguish the clinical setting from the animal models.
作者: Ovulation    時(shí)間: 2025-3-29 00:22

作者: 隱士    時(shí)間: 2025-3-29 03:09
Biochemical Control of High-Dose Methotrexate/Leucovorin Rescue Therapy, and malignant proliferating cells. Thus, under normal conditions, methotrexate (MTX) and Leucovorin (citrovorum factor, CF) in low doses can enter the cells by an active transport system, whereas in some malignancies — such as osteosarcoma — these substances only penetrate through the cell membrane
作者: ZEST    時(shí)間: 2025-3-29 09:14

作者: collagenase    時(shí)間: 2025-3-29 14:12

作者: 文件夾    時(shí)間: 2025-3-29 19:13

作者: 解決    時(shí)間: 2025-3-29 20:27
N-(Phosphonacetyl)-,-Aspartate (PALA): Current Status,olid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.
作者: 馬具    時(shí)間: 2025-3-30 03:39
,Synthesis, Biologic Effects, and Biochemical Properties of Some 2’-Azido- and 2’-Amino-2’-Deoxyarabf adenine inhibit the growth of some tumor cell lines in vitro and in vivo. 2’-Azidoarabinofuranosyl cytosine also interferes with the replication of herpes simplex virus types I and II. Whereas 2’-azidoara-C is resistant to deamination by a partially purified CdR deaminase from KB cells, the adenin
作者: MULTI    時(shí)間: 2025-3-30 04:59

作者: ANTI    時(shí)間: 2025-3-30 11:17
Vindesine: A New Vinca Alkaloid,xperimental neurotoxicity, and it inhibits the polymerization of tubulin. Its terminal half-life is 24 h and its plasma clearance is intermediate between those of vinblastine (VLB) and VCR. The maximal tolerated dose is 4–5 mg/m./week, the dose-limiting toxicity being myelosuppression (nadir by days
作者: BLINK    時(shí)間: 2025-3-30 13:00
,The Epipodophyllotoxin Derivatives VM-26 and VP-16-213, 1976–1979, a Review,od, but the greatest lethal effect is experienced in the late S and G. phases. In transplanted tumors both drugs have shown marked schedule dependency and human studies also support this..As a single agent VP 16-213 is among the most active drugs in small-cell carcinoma of the lung. Significant clin
作者: 細(xì)微差別    時(shí)間: 2025-3-30 19:55

作者: Finasteride    時(shí)間: 2025-3-30 21:07

作者: Pandemic    時(shí)間: 2025-3-31 03:50

作者: 防水    時(shí)間: 2025-3-31 05:25
1,2-Diaminocyclohexane Platinum Derivatives of Potential Clinical Value,ycin, adriamycin, Cytoxan (cyclophosphamide), vindesine, or the arabinosylcytosine (ara-C) derivatives. With these combinations, many investigators have reported on activity in germ cell tumors of the testis, carcinoma of the head and neck, penis, cervix, bladder, lung, esophagus, and ovary [1,7]. I
作者: 煤渣    時(shí)間: 2025-3-31 12:17

作者: Digest    時(shí)間: 2025-3-31 15:29
Pers?nlichkeitsst?rung und Neurose associated with high-dose infusions, contribute to the chronic toxicity of MTX administration, and cross-react to a significant degree in radioimmunoassay methods for measurement of MTX concen- trations.
作者: 聽覺    時(shí)間: 2025-3-31 17:38
Pers?nlichkeitsst?rung und Neuroset increased by the high-dose methotrexate, although the antitumor activity of the combination appears enhanced. Attempts at further increasing the intensity of this regimen or comparative trials with other therapy appears warranted.
作者: 行為    時(shí)間: 2025-3-31 23:56

作者: institute    時(shí)間: 2025-4-1 03:19
Pers?nlichkeitsst?rung und Neurosee derivatives are substrates for aminohydrolases partially purified from calf and mouse intestines. Both azido- and aminoara-C are phosphorylated by partially purified CdR kinases from leukemia L1210 and from human AML blast cells. The accumulated data encourage exploration of the clinical utility of the more potent of these analogues.
作者: FIN    時(shí)間: 2025-4-1 09:15

作者: jealousy    時(shí)間: 2025-4-1 10:32
Neurosen und Psychosen der Wechseljahre,-bound species. The clinical impact of these pharmacokinetic alterations is not currently apparent. This should be clarified with additional studies of the behavior of non-protein-bound platinum and its relationship to clinical efficacy and toxicity.
作者: 為敵    時(shí)間: 2025-4-1 16:43
Alessio Plebe,Vivian M. De La Cruzrapy, and delineation of immunologic factors in tumor control. The single, most likely contribution to a curative approach to cancer, however, is likely to emerge from the application of aggressive systemic treatment in the circumstances of minimal residual disease. This topic is covered elsewhere.
作者: Constant    時(shí)間: 2025-4-1 22:01





歡迎光臨 派博傳思國際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
崇文区| 阿瓦提县| 雷山县| 连江县| 淄博市| 开封县| 泊头市| 瑞丽市| 巴马| 龙游县| 沅江市| 石渠县| 喜德县| 易门县| 凯里市| 花垣县| 平江县| 郓城县| 嘉荫县| 锡林浩特市| 遂川县| 江阴市| 布尔津县| 山东| 钟山县| 常熟市| 大邑县| 阜平县| 鹤峰县| 桦甸市| 广州市| 万山特区| 永济市| 灯塔市| 沙洋县| 蒲城县| 精河县| 延寿县| 沅江市| 景德镇市| 大化|